Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.
Technology solutions from early phase through to post-marketing.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
Developing transformative therapies requires a flexible approach.
Partners making a difference.
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Embracing multi-indication potential during clinical development.
How AI is enhancing clinical development.
Integrating openness and precision for competitive advantage.
ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
30 May - 3 June 2025, McCormick Place, Booth #30131, Chicago, IL
16 June 2025. Register now.
ICON Cares is our commitment to making a positive impact on our people, environment and our community.
Clinical Research. Evolved.
With over 400 dedicated Cell and Gene Therapy professionals globally, ICON has developed tools and best practices to transform CGT trial design and execution.
